Study shows Oxford Covid vaccine has less protection against South African variant – The Guardian

The Oxford/AstraZeneca vaccine will not stop people becoming ill if they contract the South African variant of Covid-19, researchers have confirmed, warning that vaccines focus needs to shift from population immunity to protecting individuals from hospitalisation and death.
The small study in 2,000 people aged 31, who are less likely to become severely ill, adds to evidence from big trials of other vaccines carried out after the variant appeared in South Africa. Trial data from the Janssen and Novavax…

Click here to view the original article.